SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

Updated SOP “Consenting Research Participants and Legally Authorized Representatives” Version 2 Effective 24 October 2022

October 20, 2022 - SCI Communications

The SCI SOP “Consenting Research Participants and Legally Authorized Representatives” Version 2 will be effective on 24 October 2022.

The SOP was updated to remove the NCI CIRB requirement for a witness in all cases of remote consent as CIRB has eliminated that requirement. No other substantive changes were made. This updated SOP will be reviewed at the 20 October 2022 CCTO All Staff meeting. 

Questions regarding this new SOP should be directed to DSMC-Quality@stanford.edu 

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • PRISM
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube